Aoki Y, Hirai K, Tanikawa K
Second Department of Medicine, Kurume University School of Medicine, Fukuoka-ken, Japan.
Eur J Nucl Med. 1993 Feb;20(2):123-9. doi: 10.1007/BF00168872.
Using indium-111 tropolone-labelled platelets, a study of platelet kinetics was performed on the basis of the relationship between platelet count, platelet survival time, platelet dynamics, platelet-associated immunoglobulin G (PA-IgG) and splenic volume in 31 patients with liver cirrhosis and a platelet count of less than 100 x 10(9)/l. The mean platelet count was 46.6 +/- 25.3 x 10(9)/l, and the mean platelet survival time was 6.50 +/- 1.33 days. The mean uptake into the spleen was 43.2% +/- 14.8% on the 1st day, and 53.7% +/- 14.3% on the 7th day. The mean PA-IgG level was 107.6 +/- 66.0 ng/10(7) platelets in five patients with chronic active hepatitis who were studied as controls, the mean platelet count was 197 +/- 30 x 10(9)/l, the mean platelet survival time 9.33 +/- 0.78 days, and the mean PA-IgG 21.2 +/- 2.9 ng/10(7) platelets. The former two parameters were significantly higher (P < 0.05), and the latter significantly lower (P < 0.05). In liver cirrhosis, the platelet count showed a positive correlation with the platelet survival time and a negative correlation with PA-IgG and the splenic volume. These results suggest that the increases in both the splenic platelet pool and platelet destruction in the spleen through immunological mechanisms may influence thrombocytopenia in liver cirrhosis.
利用铟 - 111 托酚酮标记的血小板,基于 31 例血小板计数低于 100×10⁹/L 的肝硬化患者的血小板计数、血小板存活时间、血小板动力学、血小板相关免疫球蛋白 G(PA - IgG)和脾体积之间的关系,进行了一项血小板动力学研究。平均血小板计数为 46.6±25.3×10⁹/L,平均血小板存活时间为 6.50±1.33 天。第 1 天脾脏的平均摄取率为 43.2%±14.8%,第 7 天为 53.7%±14.3%。作为对照研究的 5 例慢性活动性肝炎患者的平均 PA - IgG 水平为 107.6±66.0 ng/10⁷ 血小板,平均血小板计数为 197±30×10⁹/L,平均血小板存活时间为 9.33±0.78 天,平均 PA - IgG 为 21.2±2.9 ng/10⁷ 血小板。前两个参数显著更高(P<0.05),后一个参数显著更低(P<0.05)。在肝硬化中,血小板计数与血小板存活时间呈正相关,与 PA - IgG 和脾体积呈负相关。这些结果表明,脾血小板池的增加以及通过免疫机制导致的脾脏内血小板破坏增加可能影响肝硬化中的血小板减少。